MAPT and Alzheimer disease: Studies have demonstrated the presence of senescent cells in the brains of AD patients and mouse models [5], and the pharmacological and genetic elimination of senescent cells has shown therapeutic benefits for AD pathology in mouse models of tau and amyloid pathology [11, 83, 122].